Prenatal prevention of respiratory syncytial virus bronchiolitis

References

• Nair H, Nokes DJ, Gessner BD et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet375(9725), 1545–1555 (2010).
   PubMed Web of Science ®Google Scholar
• Mitchell AA. Adverse drug reactions in utero: perspectives on teratogens and strategies for the future. Clin. Pharmacol. Ther.89(6), 781–783 (2011).
   PubMed Web of Science ®Google Scholar
• Chervenak FA, McCullough LB. An ethically justified framework for clinical investigation to benefit pregnant and fetal patients. Am. J. Bioeth.11(5), 39–49 (2011).
   PubMed Web of Science ®Google Scholar
• Connor EM, Sperling RS, Gelber R et al. Reduction of maternal–infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N. Engl. J. Med.331(18), 1173–1180 (1994).
   PubMed Web of Science ®Google Scholar
• Kari MA, Akino T, Hallman M. Prenatal dexamethasone and exogenous surfactant therapy: surface activity and surfactant components in airway specimens. Pediatr. Res.38(5), 676–684 (1995).
   PubMed Web of Science ®Google Scholar
• Healy CM, Baker CJ. Prospects for prevention of childhood infections by maternal immunization. Curr. Opin. Infect. Dis.19(3), 271–276 (2006).
   PubMed Web of Science ®Google Scholar
• Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am. J. Respir. Crit. Care Med.168(6), 633–639 (2003).
   PubMed Web of Science ®Google Scholar
• Juntti H, Osterlund P, Kokkonen J et al. Cytokine responses in cord blood predict the severity of later respiratory syncytial virus infection. J. Allergy Clin. Immunol.124(1), 52–58 (2009).
   PubMed Web of Science ®Google Scholar
• Inchley CS, Sonerud T, Fjaerli HO, Nakstad B. Reduced Dicer expression in the cord blood of infants admitted with severe respiratory syncytial virus disease. BMC Infect. Dis.11, 59 (2011).
   PubMed Web of Science ®Google Scholar
• Fjaerli HO, Bukholm G, Skjaeret C, Holden M, Nakstad B. Cord blood gene expression in infants hospitalized with respiratory syncytial virus bronchiolitis. J. Infect. Dis.196(3), 394–404 (2007).
   PubMed Web of Science ®Google Scholar
• Klemens C, Berman D, Mozurkewich E. The effect of perinatal omega-3 fatty acid supplementation on inflammatory markers and allergic diseases: a systematic review. BJOG118(8), 916–925 (2011).
   PubMed Web of Science ®Google Scholar
• Dunstan JA, Mori TA, Barden A et al. Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy. Clin. Exp. Allergy33(4), 442–448 (2003).
   PubMed Web of Science ®Google Scholar
• Lee KK, Hegele RG, Manfreda J et al. Relationship of early childhood viral exposures to respiratory symptoms, onset of possible asthma and atopy in high risk children: the Canadian Asthma Primary Prevention Study. Pediatr. Pulmonol.42(3), 290–297 (2007).
   PubMed Web of Science ®Google Scholar
• Niers L, Martin R, Rijkers G et al. The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy64(9), 1349–1358 (2009).
   PubMed Web of Science ®Google Scholar
• Prescott SL, Wickens K, Westcott L et al. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-γ and breast milk transforming growth factor-β and immunoglobin A detection. Clin. Exp. Allergy38(10), 1606–1614 (2008).
   PubMed Web of Science ®Google Scholar
• Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet357(9262), 1076–1079 (2001).
   PubMed Web of Science ®Google Scholar
• Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics121(4), e850–e856 (2008).
   PubMed Web of Science ®Google Scholar
• Kuitunen M, Kukkonen K, Juntunen-Backman K et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J. Allergy Clin. Immunol.123(2), 335–341 (2009).
   PubMed Web of Science ®Google Scholar
• Camargo CA Jr, Ingham T, Wickens K et al. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics127(1), e180–e187 (2011).
   PubMed Web of Science ®Google Scholar
• Belderbos ME, Houben ML, Wilbrink B et al. Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics127(6), e1513–e1520 (2011).
   PubMed Web of Science ®Google Scholar
• Stensballe LG, Simonsen JB, Thomsen SF et al. The causal direction in the association between respiratory syncytial virus hospitalization and asthma. J. Allergy Clin. Immunol.123(1), 131–137 (2009).
   PubMed Web of Science ®Google Scholar
• Custovic A, Simpson BM, Simpson A, Kissen P, Woodcock A. Effect of environmental manipulation in pregnancy and early life on respiratory symptoms and atopy during first year of life: a randomised trial. Lancet358(9277), 188–193 (2001).
   PubMed Web of Science ®Google Scholar
• Ochola R, Sande C, Fegan G et al. The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya. PLoS ONE4(12), e8088 (2009).
   PubMed Web of Science ®Google Scholar
• Buraphacheep W, Sullender WM. The guinea pig as a model for the study of maternal immunization against respiratory syncytial virus infections in infancy. J. Infect. Dis.175(4), 935–938 (1997).
   PubMed Web of Science ®Google Scholar
• Munoz FM, Piedra PA, Glezen WP. Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine21(24), 3465–3467 (2003).
   PubMed Web of Science ®Google Scholar